Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).

Term:forebrain monoamine hormone measurement
go back to main search page
Accession:CMO:0003091 term browser browse the term
Definition:Measurement of the amount in the forebrain of an amine compound containing one amino group and derived from an aromatic amino acid, that is produced in one part or organ of the body and initiates or regulates the activity of an organ or a group of cells in another part of the body.



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    tissue composition measurement 26
      tissue molecular composition measurement 26
        brain molecular composition measurement 3
          forebrain monoamine hormone measurement 0
            forebrain catecholamine level + 0
            forebrain serotonin level + 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    nervous system measurement 63
      central nervous system measurement 29
        brain measurement 18
          brain morphological measurement 3
            brain molecular composition measurement 3
              forebrain monoamine hormone measurement 0
                forebrain catecholamine level + 0
                forebrain serotonin level + 0
paths to the root